Full Version of the June 2012 Issue

Published: Saturday, May 19, 2012

The International Journal of Targeted Therapies in Cancer is focused on the use of targeted therapies and personalized medicine—one of the most rapidly growing and clinically challenging areas of oncology today.

This issue contains articles on:

  • Cancer Research Moves Beyond the Original “Hallmarks of Cancer”
  • ALK Rearrangements as a Therapeutic Target in Advanced Non-Small Cell Lung Cancer
  • Immunotherapy in Advanced Melanoma
  • BRAF Inhibitors in Melanoma
  • MET Inhibitors in Cancer Therapy
  • MetMAb and ARQ 197 in Non-Small Cell Lung Cancer



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x